Agostino Tafuri

Pubblicazioni

Titolo Pubblicato in Anno
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies JOURNAL OF TRANSLATIONAL MEDICINE 2021
Sirt5 inhibition induces brown fat-like phenotype in 3t3-l1 preadipocytes CELLS 2021
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies BRITISH JOURNAL OF HAEMATOLOGY 2021
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients CELL DEATH & DISEASE 2021
Clinical utility and physician perceptions of a digital platform for electronic patient-reported outcomes monitoring in patients with hematologic malignancies in real-world practice. BLOOD 2021
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols ACTA ONCOLOGICA 2021
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors BMJ SUPPORTIVE & PALLIATIVE CARE 2021
Arrhythmias and cardiogenic shock: a rare disease presentation of diffuse large B-cell lymphoma with cardiac involvement HEMATO 2021
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols ACTA ONCOLOGICA 2021
Corrigendum: Metabolic Reprogramming Promotes Myogenesis During Aging (Front. Physiol., (2019), 10, (897), 10.3389/fphys.2019.00897) FRONTIERS IN PHYSIOLOGY 2021
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment HEMATOLOGICAL ONCOLOGY 2020
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study IN VIVO 2020
The perception of the information received from the doctor. A study on 103 onco-hematological patients with metastatic disease ADVANCES IN SOCIAL SCIENCES RESEARCH JOURNAL 2020
mTOR regulation of metabolism in hematologic malignancies CELLS 2020
SARS-CoV-2 in myelodysplastic syndromes: a snapshot from early Italian experience HEMASPHERE 2020
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program BLOOD CANCER JOURNAL 2020
Matched-pair analysis of transplant from haploidentical, Unmanipulated bone marrow donor versus HLA identical sibling for patients with hematologic malignancies BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity INTERNATIONAL JOURNAL OF HEMATOLOGY 2020
Front-line therapy for elderly chronic lymphocytic leukemia patients: bendamustine plus rituximab or chlorambucil plus rituximab? Real-life retrospective multicenter study in the Lazio region FRONTIERS IN ONCOLOGY 2020
Sequential Treatments in Chronic Phase Chronic Myeloid Leukemia (CML) Patients without Optimal Response after Frontline Nilotinib or Dasatinib: An Italian CML Campus Study BLOOD 2020

ERC

  • LS1_9
  • LS2_15
  • LS3_1
  • LS3_5
  • LS4_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Studio dei meccanismi di resistenza della cellula leucemica ed identificazione del ruolo patogenetico e prognostico di profili aberranti proteomici e metabolomici implicati nei meccanismi proliferativi ed apoptotici. Sviluppo preclinico di molecole sperimentali con potenziale ruolo terapeutico target-specifico nelle onco-emopatie. Studio dei profili proteomici e metabolomici in cellule staminali  emopoietiche umane normali e nella controparte leucemica. 

Keywords

Acute leukemia
molecular targeted therapies
drug resistance
cell signaling
cell metabolism

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma